F2RL1 and colorectal adenocarcinoma: Consistent with the previous report, pretreatment of GB83 potently inhibited PAR2-AP-induced intracellular calcium increase in human colorectal adenocarcinoma HT-29 cells with IC50 of 2.1 ± 0.45 μM (Figure 1A,B).